ICAR GUIDELINES Bundle (free trial)

Rhinology and Allergy Rhinosinusitis

ICAR IFAR GUIDELINES brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1512430

Contents of this Issue

Navigation

Page 17 of 27

18 Treatment Table 6. Grade A/B Evidence-based Recommendations for Surgical Management of CRS Intervention Grade Benefit Harm Hypotensive Anesthesia B Controlled hypotension with MAPs between 60 and 70 mmHg improves the surgical field MAP <60 mmHg may result in cerebral ischemia Patient Selection to Achieve a Postoperative MCID B Use of baseline disease-specific QoL metrics (e.g., SNOT-22 ≥20) as criteria can help standardize selection for patients with high likelihood of achieving a post-op MCID Exclusion of patients based on SNOT-22 scores alone who may otherwise benefit from surgery Extent of Surgery B Reduced tissue manipulation of mucosa with limited approaches (e.g., balloons) has the potential to reduce surgical time Limited techniques can result in insufficient removal of diseased tissue, persistent inflammation, reduced topical delivery, less access for postoperative care, and faster relapse of symptoms Image Guidance B Reduced complications, improved outcomes, more extensive surgery performed, reduced surgeon stress Increased operating time, IGS failure leading to inaccurate localization of instruments

Articles in this issue

view archives of ICAR GUIDELINES Bundle (free trial) - Rhinology and Allergy Rhinosinusitis